Indications on Tuesday emerged that local production of vaccines may not commence in Nigeria till next four years.
The chairman, board of directors, BVNL, Professor Oyewale Tomori who disclosed this at a press conference in Lagos yesterday said in a bid to contribute positively and in the most sustainable way to the reduction of immunization challenges in the country, the board of directors, Biovaccines Nigeria Limited, (BVNL) has resolved to commence local production of vaccines in the next three to four years.
According to him, the board is mindful of the fact that many Nigerians and stakeholders in the health sector are in a hurry to see the country producing her own vaccines to ameliorate the big burden posed by vaccines preventable diseases particularly on the children and mothers.
Tomori said vaccines production is a highly technical and complex technology which requires time to perfect, adding that a green field project will require five to eight years gestation period.
“But we cannot wait that long. We are engaging our experts and relevant government agencies to see how we can achieve production within the next three to four years.
“As a private and independent company, Biovaccines is not encumbered by any bureaucracy and so we are confident tha with the expected co-operation from government, the management of the company will move swiftly to achieve our goals in record time,” he added.
The chairman said the board shall take calculated steps to ensure they get everything right, saying, “This means that we are not only working to give Nigerians locally produced vaccines within the quickest possible timeframe, we are also working to ensure we produce vaccines of the highest quality and that these are done in a sustainable manner.”